Tenet Healthcare (THC) Stock Forecast & Price Target

$155.34 -7.31 (-4.49%)

(As of 11/15/2024 ET)

Tenet Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 17 Analyst Ratings

Sell
0

Hold
1

Buy
16

Based on 17 Wall Street analysts who have issued ratings for Tenet Healthcare in the last 12 months, the stock has a consensus rating of "Buy." Out of the 17 analysts, 1 has given a hold rating, 13 have given a buy rating, and 3 have given a strong buy rating for THC.

Consensus Price Target

$170.38
9.68% Upside

According to the 17 analysts' twelve-month price targets for Tenet Healthcare, the average price target is $170.38. The highest price target for THC is $217.00, while the lowest price target for THC is $122.00. The average price target represents a forecasted upside of 9.68% from the current price of $155.34.

THC Analyst Ratings Over Time

Type	Current Forecast 11/18/23 to 11/17/24	1 Month Ago 10/19/23 to 10/18/24	3 Months Ago 8/20/23 to 8/19/24	1 Year Ago 11/18/22 to 11/18/23
Strong Buy	3 Strong Buy rating(s)	3 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	13 Buy rating(s)	14 Buy rating(s)	14 Buy rating(s)	13 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$170.38	$156.06	$152.69	$84.31
Forecasted Upside	9.68% Upside	-4.77% Downside	-2.24% Downside	32.28% Upside
Consensus Rating	Buy	Buy	Buy	Buy

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide

THC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

THC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Tenet Healthcare Stock vs. The Competition

Type	Tenet Healthcare	Medical Companies	S&P 500
Consensus Rating Score	3.12	2.80	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	9.68% Upside	28,534.30% Upside	9.87% Upside
News Sentiment Rating	Positive News See Recent THC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/8/2024	Barclays 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$171.00 ➝ $190.00	+14.80%
11/6/2024	Wells Fargo & Company 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$195.00 ➝ $205.00	+30.56%
10/30/2024	The Goldman Sachs Group 2 of 5 stars		Boost Target	Buy ➝ Buy	$173.00 ➝ $196.00	+23.28%
10/30/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$168.00 ➝ $177.00	+11.33%
10/30/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$174.00 ➝ $183.00	+14.07%
10/30/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$180.00 ➝ $190.00	+18.37%
2024's Must-Watch Stocks! (Ad) Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now]
10/30/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$197.00 ➝ $217.00	+36.62%
10/11/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$200.00	+30.91%
7/25/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Strong-Buy ➝ Strong-Buy	$130.00 ➝ $175.00	+17.04%
7/25/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$139.00 ➝ $171.00	+14.37%
6/28/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$150.00 ➝ $155.00	+16.40%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$107.00 ➝ $140.00	+4.67%
5/30/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$153.00	+16.31%
5/1/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$118.00 ➝ $130.00	+13.23%
5/1/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$95.00 ➝ $122.00	+8.64%
3/27/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Peer Perform ➝ Outperform	$122.00	+19.21%
11/14/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$95.00 ➝ $85.00	+45.40%
8/2/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$92.00 ➝ $98.00	+27.60%
12/6/2022	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$40.00 ➝ $45.00	+2.25%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:26 AM ET.

THC Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Tenet Healthcare is $170.38, with a high forecast of $217.00 and a low forecast of $122.00.
: 17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tenet Healthcare in the last year. There is currently 1 hold rating, 13 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" THC shares.
: According to analysts, Tenet Healthcare's stock has a predicted upside of 9.68% based on their 12-month stock forecasts.
: Over the previous 90 days, Tenet Healthcare's stock had 1 upgrade by analysts.
: Tenet Healthcare has been rated by research analysts at Barclays, Cantor Fitzgerald, KeyCorp, Royal Bank of Canada, The Goldman Sachs Group, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Tenet Healthcare more than other "medical" companies. The consensus rating for Tenet Healthcare is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how THC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Click Here For Your Free Guide

This page (NYSE:THC) was last updated on 11/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tenet Healthcare (THC) Stock Forecast & Price Target